Guillem Argilés, European Society for Medical Oncology (IMAGE)

European Society for Medical Oncology

Guillem Argilés, European Society for Medical Oncology

Caption

Abstract O-026 - 'Results of REARRANGE trial: A randomized phase 2 study comparing different dosing approaches for regorafenib (REG) during the first cycle of treatment in patients (pts) with metastatic colorectal cancer (mCRC)'will be presented by Guillem Argiles during Session XX: Colorectal Cancer (Part I) on 6 July, 09:20-10:50 CEST

Credit

Courtesy of VHIO

Usage Restrictions

The image may only be used with appropriate caption or credit

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.